First author, year
|
How grade was assessed in biopsy
|
Number of patients
|
Country
|
Grade
|
---|
Grade group
|
Grade group
|
Grade group
|
Grade group
|
Grade group
|
---|
ISUP/WHO 1
|
ISUP/WHO 2
|
ISUP/WHO 3
|
ISUP/WHO 4
|
ISUP/WHO 5
|
---|
GS ≤6
|
GS 7 (3+4)
|
GS 7 (4+3)
|
GS 8
|
GS > 8
|
---|
Athanazio 2017
|
CGG
|
2,529
|
Canada
|
NA-48-48
|
07-74-16
|
30-53-07
|
30-21-33
|
02-68-NA
|
Danneman 2016
|
Not informed
|
15,598
|
Sweden
|
NA-65-28
|
17-68-18
|
30-50-08
|
33-33-12
|
08-64-NA
|
Samaratunga 2015
|
HGS
|
2,079
|
Australia
|
NA-43-45
|
00-72-24
|
15-75-11
|
44-18-34
|
00-77-NA
|
Epstein 2012
|
HGS
|
5,071
|
US
|
NA-75-20
|
24-54-18
|
32-41-08
|
31-31-18
|
11-58-NA
|
- Note: CGG Composite Grade Group based on findings of all biopsy cores, HGS highest Gleason score in one core or region, NA not applicable